Nektar Therapeutics today presented new data from the ongoing REZOLVE-AD Phase 2b study in a late-breaking oral abstract presentation at the American College of Allergy, Asthma & Immunology (ACAAI) ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...
Keysight has expanded its power test portfolio with three families of ATE system power supplies spanning 1.5 kW to 12 kW.
North Carolina lawmakers this week begin the process of approving redrawn congressional districts for the state -- part of a nationwide, Republican-led effort to help the GOP maintain control of ...
Pharmaceutical Technology on MSN

MSD secures $700m for broad-cancer ADC asset

MSD’s deal comes in the form of $700m in funding secured from Blackstone Life Sciences. The tranche will go towards the pivotal development of sacituzumab tirumotecan (sac-TMT), an asset in Phase III ...
A specialty court in Las Vegas once covered minor crimes originating from the Strip and another popular tourism hub in ...
The family of the late San Diego Padres owner Peter Seidler is exploring the possibility of selling the franchise. The Padres announced the Seidler family’s decision to examine a sale ...
Nokia beats Q3 earnings estimates Sales ahead of expectation as AI boosts optical revenue Shares hit their highest since 2022 The company's shares were up 10.6% to 5.2 euros by 0717GMT, their highest ...
VOV.VN - The digital economy, green economy, circular economy, and creative economy are an objective requirement, a strategic ...